10-Dec-2021
Becoming a substantial holder Becoming a substantial holder

7-Dec-2021
Positive topline results from Phase 3 trial in Rett syndrome Positive topline results from Phase 3 trial in Rett syndrome

10-Nov-2021
Neuren presenting at Bell Potter Healthcare Conference Neuren presenting at Bell Potter Healthcare Conference

28-Oct-2021
Q3 2021 quarterly activity and cash flow report Q3 2021 quarterly activity and cash flow report

21-Oct-2021
Neuren receives feedback on IND for Phelan-McDermid syndrome Neuren receives feedback on IND for Phelan-McDermid syndrome

20-Oct-2021
Change of Director's Interest Notice - D Angus Change of Director's Interest Notice - D Angus

11-Oct-2021
US patent to 2034 granted for Neuren's NNZ-2591 in autism US patent to 2034 granted for Neuren's NNZ-2591 in autism

8-Oct-2021
Change of Director's Interest Notice - J Harry Change of Director's Interest Notice - J Harry

8-Oct-2021
Change of Director's Interest Notice - J Pilcher Change of Director's Interest Notice - J Pilcher

8-Oct-2021
Change of Director's Interest Notice - P Davies Change of Director's Interest Notice - P Davies